Exchange: OTC·Updated 01:56 PM EST

SOLCF News

News
all
press releases
George Scorsis takes helm as Chairman as Ropidoxuridine trial nears 50% enrollment and patent advances boost pipeline.
Stocktwits Contributor

Advertisement|Remove ads.